BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9845544)

  • 1. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.
    Lamy T; Liu JH; Landowski TH; Dalton WS; Loughran TP
    Blood; 1998 Dec; 92(12):4771-7. PubMed ID: 9845544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia.
    Liu JH; Wei S; Lamy T; Li Y; Epling-Burnette PK; Djeu JY; Loughran TP
    Blood; 2002 Aug; 100(4):1449-53. PubMed ID: 12149230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.
    Fulda S; Strauss G; Meyer E; Debatin KM
    Blood; 2000 Jan; 95(1):301-8. PubMed ID: 10607716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current concepts: large granular lymphocyte leukemia.
    Lamy T; Loughran TP
    Blood Rev; 1999 Dec; 13(4):230-40. PubMed ID: 10741898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal expansion of CD3(+)/CD4(+)/CD56(+) large granular lymphocytes and autoimmunity associated with dysregulation of Fas/FasL apoptotic pathway.
    Camagna A; Cedrone L; Caré A; Samoggia P; De Marco MC; Del Duca P; De Martinis C; Testa U
    Br J Haematol; 2001 Jan; 112(1):204-7. PubMed ID: 11167804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia.
    Perzova R; Loughran TP
    Br J Haematol; 1997 Apr; 97(1):123-6. PubMed ID: 9136951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic neutropenia mediated by fas ligand.
    Liu JH; Wei S; Lamy T; Epling-Burnette PK; Starkebaum G; Djeu JY; Loughran TP
    Blood; 2000 May; 95(10):3219-22. PubMed ID: 10807792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.
    Zauli G; Gibellini D; Secchiero P; Dutartre H; Olive D; Capitani S; Collette Y
    Blood; 1999 Feb; 93(3):1000-10. PubMed ID: 9920849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95.
    Re D; Hofmann A; Wolf J; Diehl V; Staratschek-Jox A
    Exp Hematol; 2000 Jan; 28(1):31-5. PubMed ID: 10658674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.
    Walker LS; McLeod JD; Boulougouris G; Patel YI; Ellwood CN; Hall ND; Sansom DM
    Immunology; 1999 Dec; 98(4):569-75. PubMed ID: 10594690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR.
    Pinti M; Pedrazzi J; Benatti F; Sorrentino V; Nuzzo C; Cavazzuti V; Biswas P; Petrusca DN; Mussini C; De Rienzo B; Cossarizza A
    FEBS Lett; 1999 Sep; 458(2):209-14. PubMed ID: 10481067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD95 ligand expression as a mechanism of immune escape in breast cancer.
    Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
    Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions.
    Accornero P; Radrizzani M; Delia D; Gerosa F; Kurrle R; Colombo MP
    Blood; 1997 Jan; 89(2):558-69. PubMed ID: 9002959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes.
    Gentile TC; Loughran TP
    Cell Immunol; 1995 Nov; 166(1):158-61. PubMed ID: 7585976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice.
    Lamy T; Bauer FA; Liu JH; Li YX; Pillemer E; Shahidi H; Gregory SA; Zambello R; Marcolongo R; Semenzato G; Loughran TP
    Br J Haematol; 2000 Mar; 108(4):717-23. PubMed ID: 10792274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.
    Cossarizza A; Stent G; Mussini C; Paganelli R; Borghi V; Nuzzo C; Pinti M; Pedrazzi J; Benatti F; Esposito R; Røsok B; Nagata S; Vella S; Franceschi C; De Rienzo B
    AIDS; 2000 Mar; 14(4):345-55. PubMed ID: 10770536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2.
    Loughran TP; Draves KE; Starkebaum G; Kidd P; Clark EA
    Blood; 1987 Jan; 69(1):72-8. PubMed ID: 3098327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Trentin L; Facco M; Siviero M; Galvan S; Piazza F; Perin A; Agostini C; Semenzato G
    Blood; 2000 Jul; 96(2):647-54. PubMed ID: 10887130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry.
    Szodoray P; Jellestad S; Nakken B; Brun JG; Jonsson R
    Lab Invest; 2003 Dec; 83(12):1839-48. PubMed ID: 14691302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.